Korro Bio, Inc. – NASDAQ:KRRO

Add to watchlist

$18.14

-21.86

-54.65%

Market open

Closed in about 5 hours

-18.62%

month

-18.62%

quarter

Market Cap	411.17M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-11.29

Revenue	N/A
EBITDA	-80.49M
Income	-81.18M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Korro Bio Stock Forecast

M Q Y

Last Year

$105

Potential upside: 478.83%

Analysts Price target
Financials & Ratios estimates

Korro Bio, Inc. (NASDAQ:KRRO): Profit margin
Jun 2023	0	-10.79M
Sep 2023	0	-11.61M
Dec 2023	0	-39.21M
Mar 2024	0	-19.55M

Korro Bio, Inc. (NASDAQ:KRRO): Debt to assets
Jun 2023	109345000	244.74M	223.83%
Sep 2023	46349000	9.61M	20.74%
Dec 2023	221663000	51.75M	23.35%
Mar 2024	197985000	46.62M	23.55%

Korro Bio, Inc. (NASDAQ:KRRO): Cash Flow
Jun 2023	-8.42M	19.21M	-11.66M
Sep 2023	-4.80M	6.81M	2K
Dec 2023	-39.92M	-20.36M	201.89M
Mar 2024	-21.89M	-5.61M	139K

Korro Bio alternative data

Korro Bio, Inc. (NASDAQ:KRRO): Employee count
Feb 2024	95
Mar 2024	95
Apr 2024	95
Jun 2024	101
Jul 2024	94

Korro Bio, Inc. (NASDAQ:KRRO): Insider trades (number of shares)
Period	Buy	Sel
Apr 2024	178570	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	22 Apr 2024	MAKHZOUMI MOHAMAD 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	YANG RICK 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	BASKETT FOREST 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	NEW ENTERPRISE ASSOCIATES 17, L.P. 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	FLORENCE ANTHONY A. JR. 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	MATHERS EDWARD T 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	SANDELL SCOTT D 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	ATLAS VENTURE OPPORTUNITY FUND II, L.P. 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	WALKER PAUL EDWARD 10 percent owner	Common Stock	17,857	$56	$999,992
Purchase	22 Apr 2024	CHANG CARMEN 10 percent owner 10 percent owner	Common Stock	17,857	$56	$999,992

Korro Bio
Latest News

Thursday, 21 November 2024
16:01	Korro to Participate in Upcoming Investor Conferences	globenewswire.com
07:30	Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency	globenewswire.com
Thursday, 14 November 2024
08:00	Korro to Present at the Jefferies London Healthcare Conference	globenewswire.com
Monday, 4 November 2024
07:25	Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board	globenewswire.com
Monday, 21 October 2024
10:50	Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.	investors.com
Wednesday, 16 October 2024
10:55	Wall Street Analysts Think Korro Bio, Inc. (KRRO) Could Surge 239.54%: Read This Before Placing a Bet	zacks.com
Monday, 30 September 2024
08:00	Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society	globenewswire.com
Tuesday, 27 August 2024
08:00	Korro to Participate in Upcoming September Investor and Scientific Conferences	globenewswire.com
Tuesday, 13 August 2024
16:01	Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates	globenewswire.com
Thursday, 30 May 2024
16:01	Korro to Participate in Upcoming June Investor and Scientific Conferences	globenewswire.com
Monday, 20 May 2024
14:30	Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference	globenewswire.com
Tuesday, 14 May 2024
16:01	Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer	globenewswire.com
Thursday, 18 April 2024
08:30	Korro Announces $70 Million Private Placement	globenewswire.com
Monday, 1 April 2024
16:01	Korro to Participate in Upcoming Investor Conferences	GlobeNewsWire
Thursday, 14 March 2024
17:34	Newer Treatments In Alpha-1 Antitrypsin Deficiency: $2.5 Billion/Year Market Size By 2032	Seeking Alpha
Tuesday, 27 February 2024
10:56	Wall Street Analysts Believe Korro Bio, Inc. (KRRO) Could Rally 86.94%: Here's is How to Trade	Zacks Investment Research
Friday, 16 February 2024
11:01	Best Momentum Stocks to Buy for February 16th	Zacks Investment Research
07:16	New Strong Buy Stocks for February 16th	Zacks Investment Research
Friday, 9 February 2024
10:56	Does Korro Bio, Inc. (KRRO) Have the Potential to Rally 59.66% as Wall Street Analysts Expect?	Zacks Investment Research

Frequently Asked Questions (FAQ)

What's the price of Korro Bio stock today?

One share of Korro Bio stock can currently be purchased for approximately $18.14.
When is Korro Bio's next earnings date?

Unfortunately, Korro Bio's (KRRO) next earnings date is currently unknown.
Does Korro Bio pay dividends?

No, Korro Bio does not pay dividends.
How much money does Korro Bio make?

Korro Bio has a market capitalization of 411.17M.
What is Korro Bio's stock symbol?

Korro Bio, Inc. is traded on the NASDAQ under the ticker symbol "KRRO".
What is Korro Bio's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Korro Bio?

Shares of Korro Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Korro Bio have?

As Jul 2024, Korro Bio employs 94 workers, which is 7% less then previous month and 1% less then previous quarter.
When Korro Bio went public?

Korro Bio, Inc. is publicly traded company for more then 5 years since IPO on 3 Oct 2019.
What is Korro Bio's official website?

The official website for Korro Bio is korrobio.com.
Where are Korro Bio's headquarters?

Korro Bio is headquartered at One Kendall Square, Cambridge, MA.
How can i contact Korro Bio?

Korro Bio's mailing address is One Kendall Square, Cambridge, MA and company can be reached via phone at +7 813154600.
What is Korro Bio stock forecast & price target?

Based on 1 Wall Street analysts` predicted price targets for Korro Bio in the last 12 months, the avarage price target is $105. The average price target represents a 478.83% change from the last price of $18.14.

Korro Bio, Inc.

korrobio.com

Exchange:

NASDAQ

Full time employees:

101

Industry:

Biotechnology

Sector:

Healthcare

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

+7 813154600

One Kendall Square
Cambridge, MA 02139-1562

CIK: 0001703647
ISIN: US5009461089
CUSIP: 500946108